FDA expands use of remdesivir to skilled nursing, other non-hospital settings
By
Alicia Lasek
Jan 25, 2022
Remdesivir, the first FDA-approved COVID-19 drug, now can be used in adult and pediatric patients with mild-to moderate COVID-19 illness at high risk of progressing to severe disease, the agency has announced.
Monoclonal antibodies excel in treating COVID-19 breakthrough cases, Mayo Clinic says
By
Alicia Lasek
Nov 19, 2021
Monoclonal antibody treatment lowers the odds of hospitalization by 77% in patients with COVID-19 breakthrough infections, investigators say. These SARS-CoV-2 reinfections have become more common in long-term...
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
NIH to invest an additional $515M for long COVID research
By
John Roszkowski
Feb 16, 2024
The National Institutes of Health has announced plans to provide an additional $515 million in funding over the next four years for the research and treatment of long COVID.
66 percent of nursing home residents given antibiotics during stays, researchers report
By
Alicia Lasek
Apr 09, 2023
Results from a long-term study of Medicare Part D data shed light on antibiotic prescribing prevalence, the most common drug types and rate of therapy days for U.S. nursing home residents.
Symptomless COVID infections found in almost half of US adults, CDC says
By
Alicia Lasek
Dec 05, 2022
Approximately 44% of US adults were “possibly asymptomatically infected,” between August 2021 and May 2022, blood serum evidence shows.
Study: Some 56% of people don’t know they are contagious, omicron study finds
By
Alicia Lasek
Aug 19, 2022
This lack of awareness about asymptomatic infections likely had a role in rapid transmission during the omicron wave, investigators say.
High blood pressure is well-controlled in VA nursing homes: study
By
Alicia Lasek (f3)
May 10, 2022
About 80% of residents with hypertension maintained optimal blood pressure during the study period, investigators report.
Seniors with late-onset depression have poor treatment response
By
Alicia Lasek
Apr 15, 2022
About one fifth of the patients aged 65 and older with first-time depression did not respond to antidepressant treatment during a one-year study period.
Severe breakthrough cases spiked among seniors after delta appeared: study
By
Alicia Lasek
Dec 07, 2021
The more time that had elapsed since vaccination, the greater the odds of severe reinfection illness for older patients, physicians from Yale University found. The results highlight the need for timely...